Supernus Pharmaceuticals, Inc.

SUPN · NASDAQ
Analyze with AI
$48.75+$0.43 (+0.89%)
At close:Dec 17, 2025, 5:02 PM UTC
$48.75+$0.00 (+0%)
After hours:Dec 17, 2025, 5:02 PM UTC
P/E TTM-144.21
P/B TTM0
P/S TTM0.01
Dividend Yield0%
EPS-$0.34
Beta0.718
Valuation
PEG Ratio1.12
FCF Yield6.81%
EV / EBITDA-2,723.02
Quality
ROIC-5.53%
Gross Margin90.11%
Cash Conv. Ratio2.90
Growth
Revenue 3Y CAGR-0.27%
FCF Growth54.91%
Safety
Net Debt / EBITDA-2,786.40
Interest Coverage0.00
Efficiency
Inventory Turnover0.24
Cash Conv. Cycle1,519.93

Supernus Pharmaceuticals, Inc. (SUPN) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Supernus Pharmaceuticals, Inc. (SUPN) stock price today?

As of Dec 17, 2025, 5:02 PM UTC, Supernus Pharmaceuticals, Inc. (SUPN) stock is trading at $48.75. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date SUPN stock quotes for informed trading decisions.

What is Supernus Pharmaceuticals, Inc.'s market capitalization?

Supernus Pharmaceuticals, Inc. (SUPN) has a market capitalization of approximately $2.7B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Supernus Pharmaceuticals, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the SUPN stock price changes.

What is the 52-week range for Supernus Pharmaceuticals, Inc. stock?

Supernus Pharmaceuticals, Inc. (SUPN) stock has traded in a 52-week range of $29.16 — $57.65. The 52-week range shows the highest and lowest prices at which SUPN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Supernus Pharmaceuticals, Inc. stock price to this range provides context for recent price action.

How much trading volume does Supernus Pharmaceuticals, Inc. stock have?

Supernus Pharmaceuticals, Inc. (SUPN) stock recently traded approximately 88.3K shares. Trading volume indicates market liquidity and investor interest in SUPN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Supernus Pharmaceuticals, Inc. stock.

Does Supernus Pharmaceuticals, Inc. pay dividends to shareholders?

Yes, Supernus Pharmaceuticals, Inc. (SUPN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Supernus Pharmaceuticals, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Supernus Pharmaceuticals, Inc.'s intraday price range?

Today, Supernus Pharmaceuticals, Inc. (SUPN) stock has traded in a range of $48.46 — $49.23. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring SUPN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Supernus Pharmaceuticals, Inc. stock data?

AlphaPilot sources real-time SUPN stock quotes, fundamental financial data, and historical price charts for Supernus Pharmaceuticals, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Supernus Pharmaceuticals, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of SUPN stock performance.